Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Identification and biochemical characterization of p70/sup TRK/, product of the human TRK oncogene

Journal Article · · Proc. Natl. Acad. Sci. U.S.A.; (United States)
TRK is a human transforming gene generated in a colon carcinoma by a somatic rearrangement that fused a nonmuscle tropomyosin gene to sequences that shared extensive homology with members of the tyrosine-protein kinase supergene family. These sequences are likely to be derived from a transmembrane receptor gene whose putative ligand binding domain has been replaced by tropomyosin. In the present studies, the authors have expressed the entire coding sequences of the TRK oncogene as well as its protein kinase-related carboxyl-terminal domain in Escherichia coli. Antisera raised against these bacteria-synthesized TRK polypeptides has allowed us to identify the gene product of the TRK oncogene as a 70-kDa protein. Immunoprecipitates containing p70/sup TRK/ have an associated protein kinase activity specific for tyrosine residues. Moreover, p70/sup TRK/ is phosphorylated in vivo in serine (75%), threonine (20%), and tyrosine (5%) residues. Finally, immunofluorescence and cellular fractionation studies indicate that p70/sup TRK/ is preferentially located in the cytoplasmic fraction.
Research Organization:
Frederick Cancer Research Facility, MD (USA)
OSTI ID:
7242254
Journal Information:
Proc. Natl. Acad. Sci. U.S.A.; (United States), Journal Name: Proc. Natl. Acad. Sci. U.S.A.; (United States) Vol. 84:19; ISSN PNASA
Country of Publication:
United States
Language:
English